{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:34:46Z","timestamp":1787578486185,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82573492"],"award-info":[{"award-number":["82573492"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Epidemiologic data on mesothelioma in China remain limited, particularly with respect to long-term, province-level characterization of demographic features and survival outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a 16-year retrospective cohort study of mesothelioma patients diagnosed at a major provincial tertiary referral center in China between 2009 and 2025. Among 128 identified cases, 93 met strict pathological criteria and were included for analysis. We evaluated sex distribution, anatomic site, age at diagnosis, and survival outcomes, and compared these features with representative cohorts from the United States, Europe, and Japan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our 16-year provincial cohort showed a nearly equal male-to-female ratio that markedly distinct from the male predominance reported in Western populations. Peritoneal mesothelioma accounted for 33.3% of cases, a proportion higher than that typically reported in global cohorts. The higher proportion of female patients was observed across both pleural and peritoneal mesothelioma. The median age at diagnosis was significantly younger than that observed in the United States. The median progression-free survival (PFS) and overall survival (OS) were 10\u00a0months and 16\u00a0months, with a notable survival advantage for females with peritoneal mesothelioma. Notably, only 7.5% of patients had documented asbestos exposure, indicating additional environmental and\/or genetic contributors maybe relevant in this setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This long-term provincial cohort delineates mesothelioma epidemiology at the province level in China, marked by a near-equal sex distribution with substantial female representation across disease subtypes, a high proportion of peritoneal cases, younger age at diagnosis and a low prevalence of documented asbestos exposure. These findings show clear region-specific evidence, underscoring potential geographic heterogeneity in mesothelioma epidemiology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-026-16357-9","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T03:14:06Z","timestamp":1781493246000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Distinct epidemiologic patterns of mesothelioma: evidence from a 16-year provincial cohort in China"],"prefix":"10.1186","volume":"26","author":[{"given":"Shiyuan","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4691-1761","authenticated-orcid":false,"given":"Duo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqian","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"16357_CR1","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3322\/caac.21572","volume":"69","author":"M Carbone","year":"2019","unstructured":"Carbone M, Adusumilli PS, Alexander HR Jr, Baas P, Bardelli F, Bononi A, et al. Mesothelioma: Scientific clues for prevention, diagnosis, and therapy. CA Cancer J Clin. 2019;69:402\u201329. https:\/\/doi.org\/10.3322\/caac.21572.","journal-title":"CA Cancer J Clin"},{"key":"16357_CR2","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.jtho.2022.03.014","volume":"17","author":"M Carbone","year":"2022","unstructured":"Carbone M, Pass HI, Ak G, Alexander HR Jr, Baas P, Baumann F, et al. Medical and surgical care of patients with mesothelioma and their relatives carrying germline BAP1 mutations. J Thorac Oncol. 2022;17:873\u201389. https:\/\/doi.org\/10.1016\/j.jtho.2022.03.014.","journal-title":"J Thorac Oncol"},{"key":"16357_CR3","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1200\/jco.2018.78.5204","volume":"36","author":"V Panou","year":"2018","unstructured":"Panou V, Gadiraju M, Wolin A, Weipert CM, Skarda E, Husain AN, et al. Frequency of germline mutations in cancer susceptibility genes in malignant mesothelioma. J Clin Oncol. 2018;36:2863\u201371. https:\/\/doi.org\/10.1200\/jco.2018.78.5204.","journal-title":"J Clin Oncol"},{"key":"16357_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.canlet.2017.06.028","volume":"405","author":"M Betti","year":"2017","unstructured":"Betti M, Casalone E, Ferrante D, Aspesi A, Morleo G, Biasi A, et al. Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma. Cancer Lett. 2017;405:38\u201345. https:\/\/doi.org\/10.1016\/j.canlet.2017.06.028.","journal-title":"Cancer Lett"},{"key":"16357_CR5","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/ede.0000000000001091","volume":"30","author":"TH Tran","year":"2019","unstructured":"Tran TH, Steffen JE, Clancy KM, Bird T, Egilman DS. Talc, asbestos, and epidemiology: corporate influence and scientific incognizance. Epidemiology. 2019;30:783\u20138. https:\/\/doi.org\/10.1097\/ede.0000000000001091.","journal-title":"Epidemiology"},{"key":"16357_CR6","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s10552-009-9357-4","volume":"20","author":"JE Goodman","year":"2009","unstructured":"Goodman JE, Nascarella MA, Valberg PA. Ionizing radiation: a risk factor for mesothelioma. Cancer Causes Control. 2009;20:1237\u201354. https:\/\/doi.org\/10.1007\/s10552-009-9357-4.","journal-title":"Cancer Causes Control"},{"key":"16357_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.lungcan.2007.03.016","volume":"57","author":"SM Witherby","year":"2007","unstructured":"Witherby SM, Butnor KJ, Grunberg SM. Malignant mesothelioma following thoracic radiotherapy for lung cancer. Lung Cancer. 2007;57:410\u20133. https:\/\/doi.org\/10.1016\/j.lungcan.2007.03.016.","journal-title":"Lung Cancer"},{"key":"16357_CR8","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1056\/NEJMra1912719","volume":"385","author":"SM Janes","year":"2021","unstructured":"Janes SM, Alrifai D, Fennell DA. Perspectives on the treatment of malignant pleural mesothelioma. N Engl J Med. 2021;385:1207\u201318. https:\/\/doi.org\/10.1056\/NEJMra1912719.","journal-title":"N Engl J Med"},{"key":"16357_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2486\/indhealth.39.75","volume":"39","author":"SX Cai","year":"2001","unstructured":"Cai SX, Zhang CH, Zhang X, Morinaga K. Epidemiology of occupational asbestos-related diseases in China. Ind Health. 2001;39:75\u201383. https:\/\/doi.org\/10.2486\/indhealth.39.75.","journal-title":"Ind Health"},{"key":"16357_CR10","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.21037\/tlcr-22-233","volume":"11","author":"Y Zhai","year":"2022","unstructured":"Zhai Y, Hui Z, Chen W, Ying J, Li J, Gao S. The epidemic of malignant mesothelioma in China: a prediction of incidence during. Transl Lung Cancer Res. 2022;11:2403\u201311. https:\/\/doi.org\/10.21037\/tlcr-22-233.","journal-title":"Transl Lung Cancer Res"},{"key":"16357_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1179\/2049396712y.0000000016","volume":"19","author":"SJ Henley","year":"2013","unstructured":"Henley SJ, Larson TC, Wu M, Antao VC, Lewis M, Pinheiro GA, et al. Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003\u20132008. Int J Occup Environ Health. 2013;19:1\u201310. https:\/\/doi.org\/10.1179\/2049396712y.0000000016.","journal-title":"Int J Occup Environ Health"},{"key":"16357_CR12","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.lungcan.2015.05.014","volume":"89","author":"RA Damhuis","year":"2015","unstructured":"Damhuis RA, Khakwani A, De Schutter H, Rich AL, Burgers JA, van Meerbeeck JP. Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England. Lung Cancer. 2015;89:212\u20137. https:\/\/doi.org\/10.1016\/j.lungcan.2015.05.014.","journal-title":"Lung Cancer"},{"key":"16357_CR13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/cas.16021","volume":"115","author":"S Hasegawa","year":"2024","unstructured":"Hasegawa S, Shintani Y, Takuwa T, Aoe K, Kato K, Fujimoto N, et al. Nationwide prospective registry database of patients with newly diagnosed untreated pleural mesothelioma in Japan. Cancer Sci. 2024;115:507\u201328. https:\/\/doi.org\/10.1111\/cas.16021.","journal-title":"Cancer Sci"},{"key":"16357_CR14","doi-asserted-by":"publisher","first-page":"e12007","DOI":"10.1200\/jco.2010.28.15_suppl.e12007","volume":"28","author":"K Aoe","year":"2010","unstructured":"Aoe K, Hiraki A, Fujimoto N, Gemba K, Kishimoto T. The first nationwide survival analysis of Japanese mesothelioma patients from vital statistics of Japan. J Clin Oncol. 2010;28:e12007\u2013e12007. https:\/\/doi.org\/10.1200\/jco.2010.28.15_suppl.e12007.","journal-title":"J Clin Oncol"},{"key":"16357_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/annonc\/mdh059","volume":"15","author":"MJ Byrne","year":"2004","unstructured":"Byrne MJ, Nowak AK. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol. 2004;15:257\u201360. https:\/\/doi.org\/10.1093\/annonc\/mdh059.","journal-title":"Ann Oncol"},{"key":"16357_CR16","doi-asserted-by":"publisher","unstructured":"Husain AN, Chapel DB, Attanoos R, Beasley MB, Brcic L, Butnor K, Chirieac LR, Churg A, Dacic S, Galateau-Salle F, et al. Guidelines for pathologic diagnosis of mesothelioma: 2023 update of the consensus statement from the international mesothelioma interest group. Arch Pathol Lab Med. 2024. https:\/\/doi.org\/10.5858\/arpa.2023-0304-RA.","DOI":"10.5858\/arpa.2023-0304-RA"},{"key":"16357_CR17","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1136\/thoraxjnl-2021-217709","volume":"77","author":"JP van Kooten","year":"2022","unstructured":"van Kooten JP, Belderbos RA, von der Th\u00fcsen JH, Aarts MJ, Verhoef C, Burgers JA, et al. Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study. Thorax. 2022;77:1260\u20137. https:\/\/doi.org\/10.1136\/thoraxjnl-2021-217709.","journal-title":"Thorax"},{"key":"16357_CR18","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1080\/0284186x.2021.1955971","volume":"60","author":"OT Brustugun","year":"2021","unstructured":"Brustugun OT, Nilssen Y, Eide IJZ. Epidemiology and outcome of peritoneal and pleural mesothelioma subtypes in Norway. A 20 year nation-wide study. Acta Oncol. 2021;60:1250\u20136. https:\/\/doi.org\/10.1080\/0284186x.2021.1955971.","journal-title":"Acta Oncol"},{"key":"16357_CR19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ejrad.2018.02.017","volume":"101","author":"K Kato","year":"2018","unstructured":"Kato K, Gemba K, Ashizawa K, Arakawa H, Honda S, Noguchi N, et al. Low-dose chest computed tomography screening of subjects exposed to asbestos. Eur J Radiol. 2018;101:124\u20138. https:\/\/doi.org\/10.1016\/j.ejrad.2018.02.017.","journal-title":"Eur J Radiol"},{"key":"16357_CR20","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jtho.2023.03.013","volume":"18","author":"M Carbone","year":"2023","unstructured":"Carbone M, Yang H, Pass HI, Taioli E. Did the ban on asbestos reduce the incidence of mesothelioma? J Thorac Oncol. 2023;18:694\u20137. https:\/\/doi.org\/10.1016\/j.jtho.2023.03.013.","journal-title":"J Thorac Oncol"},{"key":"16357_CR21","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1001\/jamaoncol.2016.5487","volume":"3","author":"W Mao","year":"2017","unstructured":"Mao W, Zhang X, Guo Z, Gao Z, Pass HI, Yang H, et al. Association of asbestos exposure with malignant mesothelioma incidence in Eastern China. JAMA Oncol. 2017;3:562\u20134. https:\/\/doi.org\/10.1001\/jamaoncol.2016.5487.","journal-title":"JAMA Oncol"},{"key":"16357_CR22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.46234\/ccdcw2020.078","volume":"2","author":"M Chen","year":"2020","unstructured":"Chen M, Wang H, Zhang J, Yu C, Liu W, Xu Y. Distribution of asbestos enterprises and asbestosis cases - China, 1997\u20132019. China CDC Wkly. 2020;2:305\u20139. https:\/\/doi.org\/10.46234\/ccdcw2020.078.","journal-title":"China CDC Wkly"},{"key":"16357_CR23","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jncc.2024.05.003","volume":"4","author":"Q Huang","year":"2024","unstructured":"Huang Q, Chen Y, Lian L, Lei Q, Chen J, Wu L, et al. Burden of malignant mesothelioma in China during 1990\u20132019 and the projections through 2029. J Natl Cancer Cent. 2024;4:214\u201322. https:\/\/doi.org\/10.1016\/j.jncc.2024.05.003.","journal-title":"J Natl Cancer Cent"},{"key":"16357_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3109\/01913129709021930","volume":"21","author":"RF Dodson","year":"1997","unstructured":"Dodson RF, O\u2019Sullivan M, Corn CJ, McLarty JW, Hammar SP. Analysis of asbestos fiber burden in lung tissue from mesothelioma patients. Ultrastruct Pathol. 1997;21:321\u201336. https:\/\/doi.org\/10.3109\/01913129709021930.","journal-title":"Ultrastruct Pathol"},{"key":"16357_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/modpathol.2015.121","volume":"29","author":"AD Singhi","year":"2016","unstructured":"Singhi AD, Krasinskas AM, Choudry HA, Bartlett DL, Pingpank JF, Zeh HJ, et al. The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma. Mod Pathol. 2016;29:14\u201324. https:\/\/doi.org\/10.1038\/modpathol.2015.121.","journal-title":"Mod Pathol"},{"key":"16357_CR26","doi-asserted-by":"publisher","first-page":"co2018790352","DOI":"10.1200\/jco.2018.79.0352","volume":"36","author":"S Pastorino","year":"2018","unstructured":"Pastorino S, Yoshikawa Y, Pass HI, Emi M, Nasu M, Pagano I, et al. A subset of mesotheliomas with improved survival occurring in carriers of BAP1 and other germline mutations. J Clin Oncol. 2018;36:co2018790352. https:\/\/doi.org\/10.1200\/jco.2018.79.0352.","journal-title":"J Clin Oncol"},{"key":"16357_CR27","doi-asserted-by":"publisher","first-page":"175883592513788","DOI":"10.1177\/17588359251378879","volume":"17","author":"S Yang","year":"2025","unstructured":"Yang S, Hao Y, Wang K, Xu H, Huang L, Xu L, et al. Epidemiology and clinical characteristics of mesothelioma in the Chinese population: a multicenter study. Ther Adv Med Oncol. 2025;17:17588359251378880. https:\/\/doi.org\/10.1177\/17588359251378879.","journal-title":"Ther Adv Med Oncol"},{"key":"16357_CR28","doi-asserted-by":"publisher","first-page":"e15533","DOI":"10.1111\/1759-7714.15533","volume":"16","author":"C Sun","year":"2025","unstructured":"Sun C, Yang X, Chen L, Bie Z, Kang R, Ai B, et al. A multi-center real-world study of clinicopathologic characteristics and efficacy of the malignant mesothelioma in Chinese population. Thorac Cancer. 2025;16:e15533. https:\/\/doi.org\/10.1111\/1759-7714.15533.","journal-title":"Thorac Cancer"},{"key":"16357_CR29","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/jto.0000000000000471","volume":"10","author":"M Nasu","year":"2015","unstructured":"Nasu M, Emi M, Pastorino S, Tanji M, Powers A, Luk H, et al. High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma. J Thorac Oncol. 2015;10:565\u201376. https:\/\/doi.org\/10.1097\/jto.0000000000000471.","journal-title":"J Thorac Oncol"},{"key":"16357_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1158\/0008-5472.Can-15-0751","volume":"76","author":"A De Rienzo","year":"2016","unstructured":"De Rienzo A, Archer MA, Yeap BY, Dao N, Sciaranghella D, Sideris AC, et al. Gender-specific molecular and clinical features underlie malignant pleural mesothelioma. Cancer Res. 2016;76:319\u201328. https:\/\/doi.org\/10.1158\/0008-5472.Can-15-0751.","journal-title":"Cancer Res"},{"key":"16357_CR31","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1111\/1759-7714.13491","volume":"11","author":"H Taghizadeh","year":"2020","unstructured":"Taghizadeh H, Z\u00f6chbauer-M\u00fcller S, Mader RM, M\u00fcllauer L, Klikovits T, Bachleitner-Hofmann T, et al. Gender differences in molecular-guided therapy recommendations for metastatic malignant mesothelioma. Thorac Cancer. 2020;11:1979\u201388. https:\/\/doi.org\/10.1111\/1759-7714.13491.","journal-title":"Thorac Cancer"},{"key":"16357_CR32","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1136\/oem.2006.031724","volume":"64","author":"A Burdorf","year":"2007","unstructured":"Burdorf A, J\u00e4rvholm B, Siesling S. Asbestos exposure and differences in occurrence of peritoneal mesothelioma between men and women across countries. Occup Environ Med. 2007;64:839\u201342. https:\/\/doi.org\/10.1136\/oem.2006.031724.","journal-title":"Occup Environ Med"},{"key":"16357_CR33","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3760\/cma.j.cn121094-20220815-00400","volume":"41","author":"YX Yang","year":"2023","unstructured":"Yang YX, Zhang DK, Lu HY, Zhao XL, Yu H. Change trends and related risk factors of disease burden on mesothelioma in Jiangsu Province from 1990 to 2019. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2023;41:594\u2013600. https:\/\/doi.org\/10.3760\/cma.j.cn121094-20220815-00400.","journal-title":"Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi"},{"key":"16357_CR34","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1378\/chest.122.6.2224","volume":"122","author":"S Metintas","year":"2002","unstructured":"Metintas S, Metintas M, Ucgun I, Oner U. Malignant mesothelioma due to environmental exposure to asbestos: follow-up of a Turkish cohort living in a rural area. Chest. 2002;122:2224\u20139. https:\/\/doi.org\/10.1378\/chest.122.6.2224.","journal-title":"Chest"},{"key":"16357_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1440-1843.2007.01187.x","volume":"13","author":"M Metintas","year":"2008","unstructured":"Metintas M, Metintas S, Ak G, Erginel S, Alatas F, Kurt E, et al. Epidemiology of pleural mesothelioma in a population with non-occupational asbestos exposure. Respirology. 2008;13:117\u201321. https:\/\/doi.org\/10.1111\/j.1440-1843.2007.01187.x.","journal-title":"Respirology"},{"issue":"605\u2013621","key":"16357_CR36","doi-asserted-by":"publisher","first-page":"xi","DOI":"10.1016\/s1055-3207(03)00045-0","volume":"12","author":"PH Sugarbaker","year":"2003","unstructured":"Sugarbaker PH, Welch LS, Mohamed F, Glehen O. A review of peritoneal mesothelioma at the Washington Cancer Institute. Surg Oncol Clin N Am. 2003;12(605\u2013621):xi. https:\/\/doi.org\/10.1016\/s1055-3207(03)00045-0.","journal-title":"Surg Oncol Clin N Am"},{"key":"16357_CR37","doi-asserted-by":"publisher","unstructured":"Wu X, Hernandez FV, Wang H, Wang R, Shiffka S, Shah N, Carr SR, Hoang CD, Blakely AM, Lebensohn A, et al. Prospective analysis of mesotheliomas in subjects with BAP1 cancer syndrome: clinical characteristics and epigenetic correlates of disease. J Thorac Oncol. 2025. https:\/\/doi.org\/10.1016\/j.jtho.2025.07.132.","DOI":"10.1016\/j.jtho.2025.07.132"},{"key":"16357_CR38","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.jtho.2025.06.020","volume":"20","author":"M Carbone","year":"2025","unstructured":"Carbone M, Minaai M, Kittaneh M, Krausz T, Miettinen MM, Pan Hammarstr\u00f6m Q, et al. Clinical and Pathologic phenotyping of mesotheliomas developing in carriers of germline BAP1 mutations. J Thorac Oncol. 2025;20:1683\u201398. https:\/\/doi.org\/10.1016\/j.jtho.2025.06.020.","journal-title":"J Thorac Oncol"},{"key":"16357_CR39","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1158\/2159-8290.Cd-19-1220","volume":"10","author":"M Carbone","year":"2020","unstructured":"Carbone M, Harbour JW, Brugarolas J, Bononi A, Pagano I, Dey A, et al. Biological mechanisms and clinical significance of BAP1 mutations in human cancer. Cancer Discov. 2020;10:1103\u201320. https:\/\/doi.org\/10.1158\/2159-8290.Cd-19-1220.","journal-title":"Cancer Discov"},{"key":"16357_CR40","doi-asserted-by":"publisher","first-page":"104532","DOI":"10.1016\/j.esmoop.2025.104532","volume":"10","author":"L M\u00f6hrmann","year":"2025","unstructured":"M\u00f6hrmann L, Werner M, Ole\u015b M, Knol L, Arnold JS, Mundt T, et al. Comprehensive genomic and transcriptomic analysis enables molecularly guided therapy options in peritoneal and pleural mesothelioma. ESMO Open. 2025;10:104532. https:\/\/doi.org\/10.1016\/j.esmoop.2025.104532.","journal-title":"ESMO Open"},{"key":"16357_CR41","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.jtho.2016.12.006","volume":"12","author":"Z Guo","year":"2017","unstructured":"Guo Z, Carbone M, Zhang X, Su D, Sun W, Lou J, et al. Improving the accuracy of mesothelioma diagnosis in China. J Thorac Oncol. 2017;12:714\u201323. https:\/\/doi.org\/10.1016\/j.jtho.2016.12.006.","journal-title":"J Thorac Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16357-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16357-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16357-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:11:28Z","timestamp":1787577088000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16357-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16357"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16357-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol adhered to the Declaration of Helsinki. Ethical approval was granted by the Ethics Committee of The First Affiliated Hospital of Nanjing Medical University (No.2022-SRFA-328). Informed consent was obtained verbally from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1012"}}